Profile data is unavailable for this security.
About the company
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
- Revenue in USD (TTM)193.67m
- Net income in USD4.82m
- Incorporated2001
- Employees1.10k
- LocationZynex Inc9655 Maroon CircleENGLEWOOD 80112United StatesUSA
- Phone+1 (800) 495-6670
- Websitehttps://www.zynex.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra Biomed Holdings Inc | 2.65m | -57.69m | 205.77m | 56.00 | -- | 4.47 | -- | 77.74 | -1.60 | -1.60 | 0.0734 | 1.22 | 0.0276 | 1.04 | 26.34 | 47,267.86 | -60.19 | -- | -74.93 | -- | 92.71 | -- | -2,179.34 | -- | 4.21 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Inogen Inc | 331.52m | -52.69m | 218.45m | 834.00 | -- | 1.18 | -- | 0.6589 | -2.25 | -2.25 | 14.09 | 7.78 | 1.02 | 7.81 | 8.03 | 397,506.00 | -16.21 | -8.23 | -20.38 | -9.53 | 44.22 | 44.54 | -15.89 | -10.31 | 2.34 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Utah Medical Products, Inc. | 44.08m | 15.26m | 224.52m | 169.00 | 15.10 | 1.79 | 12.23 | 5.09 | 4.27 | 4.27 | 12.36 | 36.09 | 0.3378 | 1.93 | 12.23 | 260,816.60 | 11.69 | 12.69 | 12.05 | 13.19 | 58.80 | 61.57 | 34.62 | 30.51 | 26.94 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| Electromed Inc | 57.06m | 6.47m | 235.92m | 174.00 | 38.69 | 5.72 | 32.25 | 4.13 | 0.7256 | 0.7256 | 6.40 | 4.91 | 1.23 | 3.37 | 2.42 | 327,931.00 | 13.91 | 8.64 | 16.22 | 10.09 | 76.62 | 76.26 | 11.34 | 8.06 | 5.06 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
| Trubridge Inc | 337.67m | -58.25m | 238.95m | 3.22k | -- | 1.38 | -- | 0.7076 | -4.09 | -4.09 | 23.67 | 11.57 | 0.8126 | 183.56 | 5.84 | 104,900.30 | -14.40 | 1.25 | -16.50 | 1.41 | 49.31 | 50.40 | -17.72 | 1.56 | 1.78 | 0.8055 | 0.5052 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
| LifeMD Inc | 193.06m | -25.61m | 245.06m | 207.00 | -- | -- | -- | 1.27 | -0.6409 | -0.6409 | 4.85 | -0.1847 | 3.41 | 6.21 | 36.89 | 932,652.80 | -39.18 | -153.05 | -240.82 | -526.91 | 89.64 | 83.66 | -11.49 | -45.44 | 0.7805 | -8.83 | 1.49 | -- | 28.15 | 78.90 | 51.27 | -- | 143.64 | -- |
| Atlantic International Corp | 313.06m | -68.07m | 253.24m | 7.00 | -- | 14.11 | -- | 0.8089 | -5.55 | -5.55 | 12.45 | 0.358 | 4.44 | -- | 10.48 | 44,723,330.00 | -96.45 | -71.97 | -233.48 | -106.09 | 10.81 | 61.01 | -21.74 | -1,471.82 | -- | -1.64 | 0.8328 | -- | -100.00 | -- | -37.43 | -- | -- | -- |
| Pulmonx Corp | 79.30m | -57.11m | 253.51m | 279.00 | -- | 2.70 | -- | 3.20 | -1.47 | -1.47 | 2.04 | 2.38 | 0.45 | 1.24 | 7.29 | 284,236.60 | -32.41 | -26.27 | -36.42 | -28.97 | 74.16 | 71.95 | -72.01 | -93.76 | 6.77 | -- | 0.2839 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Anika Therapeutics Inc | 164.17m | -97.52m | 255.27m | 357.00 | -- | 1.42 | -- | 1.55 | -6.64 | -6.64 | 11.14 | 12.24 | 0.5868 | 1.47 | 5.21 | 459,854.30 | -34.86 | -5.41 | -38.55 | -5.87 | 62.70 | 60.70 | -59.40 | -12.60 | 3.78 | -- | 0.00 | -- | 6.67 | 9.56 | -456.34 | -- | 3.11 | -- |
| Zynex Inc | 193.67m | 4.82m | 258.27m | 1.10k | 54.76 | 7.33 | 27.62 | 1.33 | 0.1481 | 0.1481 | 5.91 | 1.11 | 1.40 | 2.57 | 7.05 | 176,059.10 | 3.48 | 14.58 | 4.06 | 17.52 | 80.20 | 79.62 | 2.49 | 10.44 | 3.15 | 4.15 | 0.6246 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Neuropace Inc | 76.45m | -28.09m | 268.63m | 171.00 | -- | 27.28 | -- | 3.51 | -0.9924 | -0.9924 | 2.70 | 0.3299 | 0.7817 | 1.83 | 6.69 | 447,087.70 | -28.72 | -- | -33.44 | -- | 73.83 | -- | -36.74 | -- | 4.77 | -4.06 | 0.8578 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| AngioDynamics, Inc. | 292.73m | -243.03m | 282.41m | 748.00 | -- | 1.45 | -- | 0.9648 | -6.04 | -6.04 | 7.25 | 4.79 | 0.7434 | 2.27 | 6.55 | 391,344.90 | -61.72 | -16.38 | -74.39 | -18.70 | 51.71 | 52.95 | -83.02 | -30.49 | 1.41 | -- | 0.00 | -- | -10.28 | 2.35 | -251.53 | -- | 13.09 | -- |
| OraSure Technologies, Inc. | 224.26m | 11.37m | 287.19m | 638.00 | 25.57 | 0.6748 | 11.73 | 1.28 | 0.1506 | 0.1506 | 3.01 | 5.71 | 0.4862 | 2.64 | 5.58 | 351,509.40 | 2.72 | 0.7238 | 2.94 | 0.8212 | 42.26 | 46.94 | 5.59 | 1.13 | 11.20 | -- | 0.0004 | 0.00 | 4.64 | 17.41 | 413.17 | 82.20 | 10.18 | -- |
| Clearpoint Neuro Inc | 30.43m | -18.15m | 305.91m | 107.00 | -- | 10.55 | -- | 10.05 | -0.6912 | -0.6912 | 1.16 | 1.05 | 0.7242 | 1.50 | 9.66 | 284,383.20 | -43.19 | -34.75 | -51.20 | -39.67 | 60.38 | 64.75 | -59.64 | -76.91 | 3.61 | -- | 0.00 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Cerus Corp | 197.91m | -19.73m | 310.14m | 288.00 | -- | 5.80 | -- | 1.57 | -0.1076 | -0.1076 | 1.08 | 0.2882 | 1.00 | 1.97 | 7.88 | 687,194.40 | -10.01 | -25.99 | -15.26 | -40.62 | 60.52 | 61.90 | -10.00 | -35.81 | 1.92 | -1.19 | 0.6057 | -- | -0.8061 | 19.69 | 12.37 | -- | 32.07 | -- |
| Delcath Systems Inc | 22.64m | -34.12m | 314.94m | 76.00 | -- | 32.20 | -- | 13.91 | -1.36 | -1.36 | 0.8343 | 0.3059 | 0.5714 | 0.9094 | 6.34 | 297,947.40 | -86.11 | -116.57 | -156.17 | -243.21 | 81.31 | 71.02 | -150.70 | -1,235.37 | 1.03 | -172.60 | 0.1892 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
Data as of Nov 22 2024. Currency figures normalised to Zynex Inc's reporting currency: US Dollar USD
16.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.15m | 3.61% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 1.09m | 3.43% |
| Hotchkis & Wiley Capital Management LLCas of 30 Sep 2024 | 746.38k | 2.34% |
| Nantahala Capital Management LLCas of 30 Sep 2024 | 490.00k | 1.54% |
| Geode Capital Management LLCas of 30 Sep 2024 | 425.51k | 1.34% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 378.03k | 1.19% |
| Bridge City Capital LLCas of 30 Sep 2024 | 295.29k | 0.93% |
| Arrowstreet Capital LPas of 30 Sep 2024 | 258.19k | 0.81% |
| Royce & Associates LPas of 30 Sep 2024 | 257.29k | 0.81% |
| Rice, Hall, James & Associates LLCas of 30 Sep 2024 | 230.68k | 0.72% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
